Chongqing Kerui Nanhai Pharmaceutical

Chongqing Kerui Nanhai Pharmaceutical is a prominent Chinese pharmaceutical manufacturer specializing in the production of active pharmaceutical ingredients (APIs) and finished dosage forms. The company is globally recognized as a leading supplier of artemisinin and its derivatives, which are essential components in World Health Organization-recommended Artemisinin-based Combination Therapies (ACTs) for malaria. Beyond its anti-malarial portfolio, the company produces a variety of chemical drugs and traditional Chinese medicines targeting cardiovascular, respiratory, and digestive health. As a key subsidiary of the Chongqing Kerui Pharmaceutical Group, it operates large-scale, GMP-certified manufacturing facilities and maintains a significant presence in both domestic and international export markets.